CN Patent

CN108451898A — 一种克立硼罗温敏凝胶剂及其制备方法和应用

Assigned to Suzhou Shang Yi Bio Technology Co Ltd · Expires 2018-08-28 · 8y expired

What this patent protects

本发明提供了一种克立硼罗温敏凝胶剂及其制备方法和应用。以质量百分比计，该克立硼罗温敏凝胶剂包括如下原料组分：1％‑2％的克立硼罗、17％‑23％的泊洛沙姆、0.1％‑1％的改性纤维素，5％‑15％的丙二醇和/或甘油、5％‑10％的乙醇，0.01％‑0.02％的二丁基羟基甲苯，余量为水。本发明的克立硼罗温敏凝胶剂能够实现注射植入和长期释药。采用皮肤给药方式，使药物在人体发挥很好的缓释作用，并能够防止药物外渗，长时间释药。

USPTO Abstract

本发明提供了一种克立硼罗温敏凝胶剂及其制备方法和应用。以质量百分比计，该克立硼罗温敏凝胶剂包括如下原料组分：1％‑2％的克立硼罗、17％‑23％的泊洛沙姆、0.1％‑1％的改性纤维素，5％‑15％的丙二醇和/或甘油、5％‑10％的乙醇，0.01％‑0.02％的二丁基羟基甲苯，余量为水。本发明的克立硼罗温敏凝胶剂能够实现注射植入和长期释药。采用皮肤给药方式，使药物在人体发挥很好的缓释作用，并能够防止药物外渗，长时间释药。

Drugs covered by this patent

Patent Metadata

Patent number
CN108451898A
Jurisdiction
CN
Classification
—
Expires
2018-08-28
Drug substance claim
No
Drug product claim
No
Assignee
Suzhou Shang Yi Bio Technology Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.